Laurus Labs (BOM:540222) Gross Margin % : 49.85% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Laurus Labs's Gross Profit for the three months ended in Mar. 2024 was ₹7,177 Mil. Laurus Labs's Revenue for the three months ended in Mar. 2024 was ₹14,397 Mil. Therefore, Laurus Labs's Gross Margin % for the quarter that ended in Mar. 2024 was 49.85%.

The historical rank and industry rank for Laurus Labs's Gross Margin % or its related term are showing as below:

BOM:540222' s Gross Margin % Range Over the Past 10 Years
Min: 27.6 Med: 46.61 Max: 54.07
Current: 51.75

During the past 11 years, the highest Gross Margin % of Laurus Labs was 54.07%. The lowest was 27.60%. And the median was 46.61%.

BOM:540222's Gross Margin % is ranked better than
59.04% of 984 companies
in the Drug Manufacturers industry
Industry Median: 46.755 vs BOM:540222: 51.75

Laurus Labs had a gross margin of 49.85% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Laurus Labs was 3.60% per year.

Laurus Labs Gross Margin % Historical Data

The historical data trend for Laurus Labs's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Gross Margin % Chart

Laurus Labs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Gross Margin %

Get a 7-Day Free Trial

47.65

53.48

54.01

54.07

51.75

Laurus Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross Margin %	Get a 7-Day Free Trial															49.70	50.59	52.54	54.36	49.85

Competitive Comparison of Laurus Labs's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laurus Labs's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Laurus Labs's Gross Margin % falls into.

Laurus Labs Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Laurus Labs's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )	=	Gross Profit (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	26084.1	/	50408.3
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(50408.3 - 24324.2)	/	50408.3
	=	51.75 %

Laurus Labs's Gross Margin for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )	=	Gross Profit (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	7176.6	/	14396.7
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(14396.7 - 7220.1)	/	14396.7
	=	49.85 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Laurus Labs (BOM:540222) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Laurus Labs had a gross margin of 49.85% for the quarter that ended in Mar. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Laurus Labs Gross Margin % Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Laurus Labs (BOM:540222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Gross Margin %

Traded in Other Exchanges

LAURUSLABS:India

Address

Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.lauruslabs.com

Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines